Shane Bohnen Power - 15 Aug 2026 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship: SVP - General Counsel
Issuer ticker: TECH
Reported as of: 15 Aug 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 02 Nov 2026, 16:35:07 UTC
Original report date: 18 Aug 2026
Prior SEC filing: 27 Jul 2026
Next SEC filing: 19 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for Shane Bohnen pursuant to Power of Attorney previously filed.

Filing notes and source

Key filing fact

Shane Bohnen Power filed Form 4/A - Amendment for BIO-TECHNE Corp (TECH) on 02 Nov 2026.

Key facts

This page summarizes Shane Bohnen Power's Form 4/A - Amendment filing for BIO-TECHNE Corp (TECH).
8 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 02 Nov 2026, 16:35.

Change

Previous filing in this sequence was filed on 27 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001969581 Primary reporting owner

Bohnen Shane

Relationship: SVP - General Counsel
Address: 614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature: /s/ Andrew Nick as Attorney-in-Fact for Shane Bohnen pursuant to Power of Attorney previously filed.
Signature date: 02 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,420
Change %: +60%
Price: $0.000000^*
Shares after: 11,773
Date: 15 Aug 2026
Ownership: Direct

TECH transaction

Common Stock

Tax liability

Transaction value
Shares: -1,366
Change %: -12%
Price: $72.40^*
Shares after: 10,407
Date: 15 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Performance Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares: -11,929
Change %: -92%
Price: $0.000000^*
Shares after: 995
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,929
Exercise price: $84.61
Footnotes: F1

TECH transaction Derivative

Performance Restricted Stock Units

Options Exercise

Transaction value
Shares: -370
Change %: -7.7%
Price: $0.000000^*
Shares after: 4,432
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 370
Exercise price
Footnotes: F2, F3

TECH transaction Derivative

Performance Restricted Stock Units

Disposed to Issuer

Transaction value
Shares: -4,432
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,432
Exercise price
Footnotes: F2, F3

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -49
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 49
Exercise price
Footnotes: F2, F4

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,669
Change %: -50%
Price: $0.000000^*
Shares after: 1,669
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,669
Exercise price
Footnotes: F2, F5

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -2,332
Change %: -33%
Price: $0.000000^*
Shares after: 4,664
Date: 15 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,332
Exercise price
Footnotes: F2, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F3

On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited.

Footnote F4

49 restricted stock units vest on 8/15/2026.

Footnote F5

1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

Footnote F6

2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.